BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 30165291)

  • 21. Thalamus volume and ambulation in multiple sclerosis: a cross-sectional study.
    Motl RW; Zivadinov R; Bergsland N; Benedict RH
    Neurodegener Dis Manag; 2016; 6(1):23-9. PubMed ID: 26782314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impairments in Walking Ability, Dexterity, and Cognitive Function in Multiple Sclerosis Are Associated with Different Regional Cerebellar Gray Matter Loss.
    Grothe M; Lotze M; Langner S; Dressel A
    Cerebellum; 2017 Dec; 16(5-6):945-950. PubMed ID: 28612183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study to validate the expanded timed get-up-and-go in a population with multiple sclerosis.
    Jakimovski D; Kavak KS; Zakalik K; Bromley L; Ozel O; Qutab N; Eckert SP; Kolb C; Weinstock-Guttman B
    Mult Scler J Exp Transl Clin; 2022; 8(2):20552173221099186. PubMed ID: 35571975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative measures of walking and strength provide insight into brain corticospinal tract pathology in multiple sclerosis.
    Fritz NE; Keller J; Calabresi PA; Zackowski KM
    Neuroimage Clin; 2017; 14():490-498. PubMed ID: 28289599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concentrations of immunoglobulin free light chains in cerebrospinal fluid predict increased level of brain atrophy in multiple sclerosis.
    Nazarov V; Makshakov G; Kalinin I; Lapin S; Surkova E; Mikhailova L; Gilburd B; Skoromets A; Evdoshenko E
    Immunol Res; 2018 Dec; 66(6):761-767. PubMed ID: 30635824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional but not global brain damage contributes to fatigue in multiple sclerosis.
    Rocca MA; Parisi L; Pagani E; Copetti M; Rodegher M; Colombo B; Comi G; Falini A; Filippi M
    Radiology; 2014 Nov; 273(2):511-20. PubMed ID: 24927473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis.
    Maghzi AH; Revirajan N; Julian LJ; Spain R; Mowry EM; Liu S; Jin C; Green AJ; McCulloch CE; Pelletier D; Waubant E
    Mult Scler Relat Disord; 2014 Nov; 3(6):720-7. PubMed ID: 25891551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal changes of deep gray matter shape in multiple sclerosis.
    Tsagkas C; Geiter E; Gaetano L; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Kappos L; Sprenger T; Granziera C; Mallar Chakravarty M; Magon S
    Neuroimage Clin; 2022; 35():103137. PubMed ID: 36002960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients.
    Sbardella E; Petsas N; Tona F; Prosperini L; Raz E; Pace G; Pozzilli C; Pantano P
    PLoS One; 2013; 8(5):e63250. PubMed ID: 23696802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis.
    Yik JT; Becquart P; Gill J; Petkau J; Traboulsee A; Carruthers R; Kolind SH; Devonshire V; Sayao AL; Schabas A; Tam R; Moore GRW; Li DKB; Stukas S; Wellington C; Quandt JA; Vavasour IM; Laule C
    Mult Scler Relat Disord; 2022 Jan; 57():103366. PubMed ID: 35158472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cortical and Deep Gray Matter Perfusion Associations With Physical and Cognitive Performance in Multiple Sclerosis Patients.
    Jakimovski D; Bergsland N; Dwyer MG; Traversone J; Hagemeier J; Fuchs TA; Ramasamy DP; Weinstock-Guttman B; Benedict RHB; Zivadinov R
    Front Neurol; 2020; 11():700. PubMed ID: 32765407
    [No Abstract]   [Full Text] [Related]  

  • 32. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
    Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J
    Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression.
    Nakamura Y; Gaetano L; Matsushita T; Anna A; Sprenger T; Radue EW; Wuerfel J; Bauer L; Amann M; Shinoda K; Isobe N; Yamasaki R; Saida T; Kappos L; Kira JI
    J Neuroinflammation; 2018 Sep; 15(1):255. PubMed ID: 30185189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential changes in deep and cortical gray matters of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.
    Zhou F; Zee CS; Gong H; Shiroishi M; Li J
    J Comput Assist Tomogr; 2010; 34(3):431-6. PubMed ID: 20498549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
    Motl RW; Cadavid D; Sandroff BM; Pilutti LA; Pula JH; Benedict RH
    J Neurol Sci; 2013 Dec; 335(1-2):169-73. PubMed ID: 24104065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. White Matter Tract Injury is Associated with Deep Gray Matter Iron Deposition in Multiple Sclerosis.
    Bergsland N; Tavazzi E; Laganà MM; Baglio F; Cecconi P; Viotti S; Zivadinov R; Baselli G; Rovaris M
    J Neuroimaging; 2017 Jan; 27(1):107-113. PubMed ID: 27239049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
    Kearney H; Schneider T; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):608-14. PubMed ID: 25097217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between cognition and motor performance is beyond structural damage in relapsing-remitting multiple sclerosis.
    Mistri D; Cacciaguerra L; Storelli L; Meani A; Cordani C; Rocca MA; Filippi M
    J Neurol; 2022 Aug; 269(8):4213-4221. PubMed ID: 35278104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.
    Gaetano L; Häring DA; Radue EW; Mueller-Lenke N; Thakur A; Tomic D; Kappos L; Sprenger T
    Neurology; 2018 Apr; 90(15):e1324-e1332. PubMed ID: 29540589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O; Gouveia A; Batista S; Moura C; Machado E
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.